The Food and Drug Administration (FDA) carried out an inspection for drug quality assurance at Eurofins Infinity Laboratory Group, Inc. in Crown Point on March 5, according to data posted on the FDA’s website.
The inspection report concluded that Eurofins Infinity Laboratory Group, Inc. was not required to make any changes to its operational management.
The FDA regularly conducts inspections at facilities nationwide to ensure compliance with laws and regulations overseen by the agency, which are designed to enhance public health. Results of these inspections are made available publicly.
According to its website, the FDA is the government agency mainly tasked with overseeing the safety and quality of human and animal drugs, biological products, medical equipment, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
